229 related articles for article (PubMed ID: 27703211)
1. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.
McDermott N; Meunier A; Mooney B; Nortey G; Hernandez C; Hurley S; Lynam-Lennon N; Barsoom SH; Bowman KJ; Marples B; Jones GD; Marignol L
Sci Rep; 2016 Oct; 6():34796. PubMed ID: 27703211
[TBL] [Abstract][Full Text] [Related]
2. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
Scott SL; Earle JD; Gumerlock PH
Cancer Res; 2003 Nov; 63(21):7190-6. PubMed ID: 14612513
[TBL] [Abstract][Full Text] [Related]
3. Generation of Radioresistant Prostate Cancer Cells.
Marignol L
Methods Mol Biol; 2023; 2645():129-138. PubMed ID: 37202614
[TBL] [Abstract][Full Text] [Related]
4. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy.
Wu CT; Chen WC; Liao SK; Hsu CL; Lee KD; Chen MF
Endocr Relat Cancer; 2007 Sep; 14(3):633-43. PubMed ID: 17914094
[TBL] [Abstract][Full Text] [Related]
5. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
[TBL] [Abstract][Full Text] [Related]
9. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance.
Kuwahara Y; Roudkenar MH; Urushihara Y; Saito Y; Tomita K; Roushandeh AM; Sato T; Kurimasa A; Fukumoto M
Med Mol Morphol; 2017 Dec; 50(4):195-204. PubMed ID: 29067564
[TBL] [Abstract][Full Text] [Related]
11. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro.
Xu QY; Gao Y; Liu Y; Yang WZ; Xu XY
Chin Med J (Engl); 2008 Sep; 121(18):1830-7. PubMed ID: 19080366
[TBL] [Abstract][Full Text] [Related]
12. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
13. Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.
Inder S; Bates M; Ni Labhrai N; McDermott N; Schneider J; Erdmann G; Jamerson T; Belle VA; Prina-Mello A; Thirion P; Manecksha PR; Cormican D; Finn S; Lynch T; Marignol L
Sci Rep; 2019 Nov; 9(1):17325. PubMed ID: 31758038
[TBL] [Abstract][Full Text] [Related]
14. Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.
McDermott N; Meunier A; Wong S; Buchete V; Marignol L
Clin Transl Radiat Oncol; 2017 Feb; 2():63-68. PubMed ID: 29658003
[TBL] [Abstract][Full Text] [Related]
15. Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.
Lynam-Lennon N; Reynolds JV; Pidgeon GP; Lysaght J; Marignol L; Maher SG
Radiat Res; 2010 Dec; 174(6):703-11. PubMed ID: 21128793
[TBL] [Abstract][Full Text] [Related]
16. Fractionated radiation therapy can induce a molecular profile for therapeutic targeting.
John-Aryankalayil M; Palayoor ST; Cerna D; Simone CB; Falduto MT; Magnuson SR; Coleman CN
Radiat Res; 2010 Oct; 174(4):446-58. PubMed ID: 20726711
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.
Morel KL; Ormsby RJ; Bezak E; Sweeney CJ; Sykes PJ
Radiat Res; 2017 May; 187(5):501-512. PubMed ID: 28398879
[TBL] [Abstract][Full Text] [Related]
18. Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation.
Scott SL; Gumerlock PH; Beckett L; Li Y; Goldberg Z
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):219-27. PubMed ID: 15093919
[TBL] [Abstract][Full Text] [Related]
19. Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
Seki M; Teishima J; Mochizuki H; Mutaguchi K; Yasumoto H; Oka K; Nagamatsu H; Shoji K; Matsubara A
Hiroshima J Med Sci; 2013 Mar; 62(1):13-9. PubMed ID: 23600329
[TBL] [Abstract][Full Text] [Related]
20. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
